YURASOV SERGEY (Sr. VP, Clinic. Devel. & CMO) sold 4.3% of their position (3.52K shares) of IMMUNE DESIGN CORP. on the open market
Open‑market sale worth $5.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/7/2019ACC: 0001209191-19-002669
Officer· Sr. VP, Clinic. Devel. & CMO
Since Jul 2018
+131.48K
Net shares
Net buyer
$5.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
135K acquired · 3.52K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+25K
Price / share
—
Trade value
—
% of position
43.6%
1/3/2019
57.28K→82.28K
Common Stock
Direct
Shares
−3.52K
Price / share
$1.57
Trade value
$5.54K
% of position
4.3%
1/7/2019
82.28K→78.76K
Total
Net shares
+21.48K
Net value
-$5.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2019 | A · Award | +25K | — | — | 43.6% | 57.28K | 82.28K |
| Common Stock Direct | 1/7/2019 | S · Sale | −3.52K | $1.57 | $5.54K | 4.3% | 82.28K | 78.76K |
| Total | +21.48K | -$5.54K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
110K shares
Shares
+110K
Strike price
1.31
Held after
110K
Exercisable
—
1/3/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock110K shares | 1/3/2019 | A · Award | +110K | 1.31 | — | 110K |